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Abstract 
Background: The evolution in the surgical and diagnostic procedures, the attention to women’s preferences, the 
case mix, and differences in professional practices may lead to a variability in the quality of breast cancer clinical 
pathway. To catch and manage this variability it is important to use valid measures. The aim of this paper is to examine 
the concurrent validity of the breast-conserving surgery (BCS) indicator and to provide evidence to guide the quality 
improvement process.
Methods: The BCS indicator was calculated using hospital discharge records (HDRs) and was validated against surgi-
cal registry (SR) data in a random sample of 336 women undergoing breast cancer surgery in 2012 in two Tuscan 
teaching hospitals. The concurrent validity of BCS was examined by cross-tabulating patients using the ICD-9 CM 
codes for breast surgery obtained from the two data sources.
Results: The analysis, carried out involving breast cancer professionals, highlighted that the large majority of inter-
ventions coded as “mastectomies” in HDRs are in fact reconstructing procedures, including nipple-sparing, skin-
sparing and skin-reducing mastectomies in SR. These results led us to refine the old algorithm, that calculates the 
proportion of breast-conserving surgery over the total number of breast interventions, and reclassify breast cancer 
surgical procedures into three categories: conservative, reconstructive and traditional mastectomy. Based on this new 
classification algorithm, the percentages of (I) reconstructive interventions were 16% at Florence TH and 38.3% at Pisa 
TH; (II) breast-conserving interventions were respectively 72.8 and 52.1%; and (III) mastectomies 11.2 and 9.6%. After 
adjusting for age in a logistic regression model, the percentages of reconstructive interventions at Florence and Pisa 
were respectively 22 and 34% and those of breast-conserving interventions 63 and 53%.
Conclusions: Our results indicate that breast cancer care indicators should be refined by distinguishing reconstruc-
tive procedures (nipple/skin-sparing surgery with implant or breast tissue expander insertion) from traditional mas-
tectomy. The involvement of breast care professionals in the choice of indicators proved to be crucial to capture the 
up-to-date breast cancer surgical practice and inform the quality improvement process.
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Background
Breast cancer is the most common cancer in women 
worldwide, with an estimated number of 464,000 cases 
in Europe in 2012 [1]. Due to its burden and related 
impact on healthcare services, quality of care assessment 
in breast cancer has become a central issue for policy 
makers and clinicians, to ensure that patients receive the 
highest standards of care [2–4]. Therefore quality targets 
and accreditation requirements for hospitals and breast 
units have been identified [5–7].
The European Society of Breast Cancer Specialist 
(EUSOMA) has defined quality indicators, linked to spe-
cific targets, in order to routinely measure and monitor 
the capacity of the breast units to ensure high-quality 
clinical outcomes [5, 6]. One of these indicators is the 
“Proportion of women with invasive breast cancer with 
a size <3  cm who underwent breast-conserving surgery 
(BCS)” and the target suggested by EUSOMA for this 
indicator is 70% (optimum level 80%) [5].
Recent European studies based on registries linked with 
claims data or hospital discharge records (HDRs) showed 
proportions of conservative interventions below these 
targets and with stable or decreasing trends [2, 8–10]. A 
recent study from Catalunia based on HDRs showed a 
significant increase in the percentage of patients treated 
with breast-conserving surgery (from 67.9% in 2005 to 
74.0% in 2011). Of note, in this study, a decreasing trend 
was observed in high-tech hospitals, contrary to that 
observed in hospitals of medium and low complexity 
[11]. The BCS indicator computed using data from the 
nationwide mammography screening in Denmark ranged 
from 69.7 to 86.5% [12].
A large variability in BCS was also observed in Italy. 
This indicator, based on HDRs, is included in the perfor-
mance evaluation system developed by the Management 
and Health Laboratory of the Scuola Superiore Sant’Anna 
of Pisa, Tuscany [13]. The Italian Parliamentary Commis-
sion inquiring on the efficiency and effectiveness of the 
National Health System [14] and, successively, a network 
of ten Italian Regions used the BCS indicator to measure 
the quality of surgery in breast cancer care. Moreover, a 
normative resolution of Tuscany Region, one of the ten 
Regions in the network, introduced the BCS indicator 
to monitor the performance of the breast units [15]. To 
this purpose, using routine administrative data may have 
several advantages, as they are readily available and can 
be used on a systematic basis [16]. In Tuscany Region, 
where the regional governance uses performance indica-
tors, including the BCS indicator, to measure quality of 
care and set targets to guide the quality improvement 
process, health professionals are systematically involved 
in selecting and refining performance indicators. Indeed 
indicators should be used to guide the care improvement 
process and should be able to change the clinicians and 
healthcare organizations behavior [17, 18].
In the case of breast cancer surgery, the Tuscan clini-
cians agreed to use the BCS indicator. Inter-hospital 
comparison revealed a large variability among providers 
(from 65.9 to 90.3%) and low values for the three Tuscan 
teaching hospitals, surprising professionals themselves. 
Indeed, the finding of slightly lower proportions of BCS 
in high-complexity hospitals, which usually have high 
caseloads, is apparently counterintuitive and in contrast 
with the literature reporting that higher volumes are pos-
itively associated with better practices and outcomes [19] 
and in particular with a better chance of receiving a con-
servative intervention [20–22].
A possible source of variability in the BCS indicator 
is variability in coding diagnoses and procedures in the 
hospital discharge records database. Moreover, the case 
mix may be a possible, obvious, explanation of the differ-
ences between hospitals. Last but not least, in the recent 
years many changes occurred in the breast cancer care 
management, in particular the combination of breast 
oncologic and reconstructive surgery has revolutionized 
the surgical approach to breast cancer.
The aim of this paper is to examine the concurrent 
validity of the BCS indicator to determine whether it 
reflects accurately the ongoing choices in surgical prac-
tice, in particular in the teaching hospitals.
This was done by analyzing the possible reasons of the 
low proportions of BCS in two high-volume teaching 
hospitals of Tuscany Region, as measured by the tradi-
tional BCS indicator, to determine whether the BCS indi-
cator is up-to-date and valid to monitor appropriateness 
and quality of breast cancer care and to guide the quality 
improvement process.
Methods
Setting
The Italian National Health Care System (NHS) is a pub-
lic health system providing universal coverage for com-
prehensive and essential health services through general 
taxation. This public system should ensure the achieve-
ment of equitable access to health care regardless of 
individual ability to pay or other characteristics such as 
income and region of residence. Since the early 1990s, a 
strong policy of decentralization has been taking place in 
Italy and powers have gradually shifted from the state to 
the 21 Italian regions. These regions now have political, 
administrative, and financial responsibility regarding the 
provision of health care.
Since 2008 a network of Italian Regions have been 
using a performance evaluation system, developed by 
Laboratorio Management e Sanità of the Scuola Supe-
riore Sant’Anna in Pisa (Italy) [23] as a governance tool 
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aimed to manage and improve the performance of 
healthcare organizations and ensure appropriate and 
equitable answers to population’ needs. Since 2012, these 
ten Regions have included the BCS indicator among the 
performance indicators. In particular, Tuscany Region 
has undertaken a process of engagement of the breast 
cancer care professionals by sharing indicators to meas-
ure quality of care. The engagement of professionals is 
essential to drive improvement strategies, changing clini-
cians’ behaviors and practices [24–28].
Design and data sources
In the 2014 Tuscan cancer care professionals took part 
in a study promoted by the Regional Health Department 
with the aim to analyze the determinants of the inter-hos-
pital variability of BCS indicator. Using a shared protocol, 
the professionals and a team of researchers extracted and 
analyzed anonymous data from both regional and local 
databases including information on diagnosis and surgi-
cal procedures delivered to women with breast cancer 
during the hospital stay. The data sources were:
(1) The HDR database, which routinely collects data on 
hospital discharges, including referral source, dis-
charge status, up to six discharge diagnoses (ICD-
9-CM), up to six hospital procedures (ICD-9-CM) 
and patient’s demographic data.
(2) The surgical registry (SR) database, which includes 
a description of the interventions, the date and the 
time of the interventions.
(3) The pathology registry database includes the histo-
logical diagnosis, the presence of a sentinel lymph 
node and/or other lymph nodes, the tumor size and 
staging.
A random sample of 400 cases was extracted from the 
HDR database of the two Teaching Hospitals in Tuscany 
(Pisa TH and Florence TH). Women diagnosed with 
breast cancer (ICD-9-CM code 174*), who underwent a 
surgical intervention (ICD-9-CM procedure codes 85.2*, 
85.3*, 85.4*) in the year 2012, were considered eligible for 
the study. We included only incident interventions, and 
excluded re-interventions within 4  months. The BCS 
indicator, based on the existing algorithm for HDR data, 
was first computed. It distinguishes conservative surgi-
cal interventions (ICD-9-CM procedure codes 85.2* and 
85.3*) from traditional mastectomy (ICD 9-CM proce-
dure code 85.4).
Data from the SR were then linked with the HDRs of 
Pisa and Florence samples by using as a key the medi-
cal record’s code. Then, using SR information, we coded 
interventions as conservative when quadrantectomy or 
lumpectomy was reported, reconstructive when nipple 
sparing, skin sparing mastectomy or skin-reducing mas-
tectomy with prosthesis insertion were reported, and 
mastectomy elsewhere.
The validation of the BCS indicator was done by 
cross-tabulating patients using the HDR classification 
(breast-conserving and mastectomy procedures) and that 
derived from SR. All discrepant cases were examined in 
detail in order to identify different coding practices of 
interventions.
After a review of the textual description of the SR 
interventions, the old BCS indicator was refined by 
distinguishing reconstructive procedures from con-
servative procedures and mastectomies and the corre-
sponding ICD-9-CM were used to define a new algorithm 
(Table 1). In this algorithm, based on HDR data, proce-
dures were defined as conservative if they included exci-
sion or destruction of breast tissue or unilateral/bilateral 
reduction mammoplasty; reconstructive if they included 
implant breast reconstruction or the insertion of breast 
tissue expander, and mastectomies elsewhere. Lastly, 
after calculating the indicator using the new algorithm, 
we compared the probabilities of the different surgical 
procedures between the two hospitals after adjusting for 
age using logistic regression models. Data were analyzed 
using SAS Version 9.2.
Table 1 ICD-9CM codes for conservative, reconstructive and mastectomy interventions
Type of intervention Old algorithm’s HDR codes New algorithm’s HDR codes
Conservative 85.2* Excision or destruction of breast tissue or
85.3* Reduction mammoplasty  
and subcutaneous mammectomy
85.2* Excision or destruction of breast tissue or
85.31 Unilateral reduction mammoplasty or
85.32 Bilateral reduction mammoplasty or
Reconstructive 85.4* + 85.53 Unilateral breast implant or
85.4* + 85.54 Bilateral breast implant or
85.4* + 85.95 Insertion of breast tissue expander or
85.33 Unilateral subcutaneous mammectomy with synchronous implant or
85.35 Bilateral subcutaneous mammectomy with synchronous implant
85.34 Other unilateral subcutaneous mammectomy or + 85.53/85.54/85.95
85.36 Other bilateral subcutaneous mammectomy + 85.53/85.54/85.95
Mastectomy 85.4* Mastectomy 85.4* Mastectomy
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Results
In 2012, 622 interventions were performed at Florence 
teaching hospital (TH) and 611 at Pisa TH. After ran-
domly extracting 200 records from the HDR database 
for each hospital and excluding re-interventions (n =  23 
for Florence TH) and patients for whom SR informa-
tion was not available (n = 8 for Florence TH and n = 33 
for Pisa TH), the final samples were N  =  169 at Flor-
ence TH and N  =  167 at Pisa TH. Mean age  ±  SD of 
women was 60.1 ± 13.6 at Florence TH and 58.0 ± 13.3 
for Pisa TH (t test  =  1.46, p  =  0.146). Tumor size was 
1.67 ± 1.01 for patients discharged from Florence TH and 
1.51 ± 0.81 for patients from Pisa TH (Wilcoxon rank-sum 
test = 21,773.5, p = 0.1786). Staging distribution was simi-
lar in the two hospitals, with no statistically significant dif-
ference (χ2 test = 6.7023, p = 0.082), as shown in Table 2.
The BCS indicator based on HDRs was 73.4% at Flor-
ence TH and 62.9% at Pisa TH (Table 3), and that based 
SR data was 73.4% at Florence TH and 52.1% at Pisa TH.
A large number of cases classified as “mastectomies” 
in HDRs (68.9% at Florence TH and the 74.2% at Pisa 
TH) proved to be reconstructive procedures (including 
nipple-sparing, skin-sparing and skin-reducing mastec-
tomies) in the SR. Thus, after applying the new algorithm 
we reclassified HDR breast cancer surgical procedures 
into three categories: conservative, reconstructive and 
traditional mastectomy. Interventions with both conserv-
ative and reconstructive codes were recoded as recon-
structive; those with both conservative and mastectomy 
codes were recoded as mastectomy and lastly interven-
tions with both mastectomy codes and 85.33 or 85.35 
were recoded as reconstructive.
Based on this new classification algorithm, the per-
centages of (I) reconstructive interventions were 16% at 
Florence TH and 38.3% at Pisa TH; (II) breast-conserving 
interventions were respectively 72.8 and 52.1%; and (III) 
traditional mastectomies 11.2 and 9.6% (Table 4). To be 
consistent with EUSOMA BCS indicator, we conducted 
a secondary analysis by excluding 12 patients in Florence 
TH and eight in Pisa TH with tumors >3  cm. The per-
centage of reconstructive interventions changed to 15.3% 
at Florence TH and 39% at Pisa TH; breast-conserving 
interventions were 75.8 and 52.8%; and traditional mas-
tectomies 8.9 and 8.2%. Percentages calculated with the 
two methods did not differ significantly.
In order to examine the breast surgery practice of the 
two hospitals in detail, the three indicators were calcu-
lated for five age groups. Results indicate that reconstruc-
tive interventions were more common among women 
under 40  years as compared with those in other age 
groups, at Florence TH and Pisa TH (Fig. 1).
On the contrary traditional mastectomies were more 
common among older patients, being performed in 29 
and 33% of patients >70 years. After adjusting for age in a 
logistic regression model, the percentages of reconstruc-
tive interventions at Florence and Pisa were respectively 
22 and 34% and those of breast-conserving interventions 
and 63 and 53%.
Table 2 Tumor stage distribution for Florence TH and Pisa 
TH
χ2 test = 6.7023, p = 0.082
Tumor stage Teaching hospital
Florence Pisa
0 2.74% (4) 9.43% (15)
I 54.79% (80) 54.72% (87)
II 31.51% (46) 28.30% (45)
III or more 10.96% (16) 7.55% (12)
Total 100% (146) 100% (159)
Table 3 Cross-tabulation of  the number of  mastectomies and  conservative surgery as  derived from  the existing algo-
rithm based on HDR data and from surgical registry data in the two study hospitals
Surgical registry Total
Conservative Reconstructive Mastectomy
Florence
 HDR database
  Conservative: (85.2*, 85.3*) 72.8% (123) 0.6% (1) 0 73.4% (124)
  Mastectomy (85.4*) 0.6% (1) 17.8% (30) 8.3% (14) 26.6% (45)
 Total 73.4% (124) 18.3% (31) 8.3% (14) 100% (169)
Pisa
 HDR database
  Conservative: (85.2*, 85.3*) 52.1% (87) 10.8% (18) 0 62.9% (105)
  Mastectomy (85.4*) 0 27.5% (46) 9.6% (16) 37.1% (62)
 Total 52.1% (87) 38.3% (64) 9.6% (16) 100% (167)
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Discussion
Breast-conserving surgery followed by adjuvant radio-
therapy has been the gold standard for invasive and 
unifocal breast cancer since the 1980s. The indica-
tions of the Italian Ministry of Health, issued in 2010 
(http://www.salute.gov.it/imgs/C_17_pubblicazi-
oni_1700_allegato.pdf ), read: ‘Surgery is based on par-
tial resection or quadrantectomy when the size of the 
tumor is within the anatomical limits of a conservative 
surgery. The ratio between the breast volume and the 
size of the excision should be favorable to the complete 
removal of the neoplasm with an acceptable esthetic 
result.’
Thus, in our algorithm we labeled as conservative all 
local interventions including lumpectomy quadrantec-
tomy or mammoplasty reduction.
However, in recent years, the preoperative genetic 
screening and diagnostic imaging, the development of 
new surgical techniques and the higher attention on the 
esthetic and psychological outcomes have produced the 
spread of reconstructive procedures [29, 30]. Therefore, 
updating quality of care indicators is necessary in order 
to make them more sensitive to clinical practice changes 
and technical progress.
Our results indicate that the apparently low percent-
age of conservative procedures in teaching hospital is 
due to the inclusion of reconstructive procedures among 
mastectomies.
The update of the coding algorithm allowed us to 
establish that traditional mastectomies were about 10% 
in both hospitals, in line with EUSOMA standards.
We argue that the breast-conserving procedures indica-
tor should be complemented with the reconstructive pro-
cedures indicator to provide a more accurate description 
of the ongoing breast cancer surgery practice in the hos-
pital and to monitor inter-hospital variability.
The present study shows how immediate breast recon-
struction is an increasingly common practice in breast 
cancer surgery, performed in 16% (Florence TH) and 
38.3% (Pisa TH) of women, with a peak at younger ages. 
Our results are consistent with Yang et al., who reported 
that the percentage of immediate breast reconstruction 
declines with age, and has a maximum in the age group 
<40 years [31].
We found that the large difference in the percentage of 
reconstructive procedures between the two study hospi-
tals was only partially accounted by the lower mean age 
of women undergoing surgery at Pisa TH, suggesting that 
other clinical factors, organizational factors or patients’ 
decisions play an important role. One explanation is that 
the diagnostic procedures adopted in the two hospitals dif-
fered: MRI and preoperative genetic screening was more 
frequent in Pisa than in Florence, as reported by the breast 
unit teams of the two hospitals. The more frequent use 
of MRI facilitates the identification of multifocal tumors 
and might have led to the surgeon’s decision to undertake 
reconstructive surgery instead of a conservative procedure.
Our study has several strengths that should be con-
sidered. First, the Italian National Health System has 
a universal coverage; therefore, we could assume that 
individual economic resources did not account for the 
variability of the indicator among hospitals. Second, 
Table 4 Cross-tabulation of the number of mastectomies and conservative surgery as derived from HDR data and surgi-
cal registry data in the two study hospitals, using the new classification algorithm
a This case was a quadrantectomy wrongly classified as 85.4*
b In 4 cases, in addition to code 85.4, we found codes 85.89 (other mammoplasty), 86.70 (free flap reconstruction) or 86.93 (insertion of generic tissue expander)
Surgical registry Total
Conservative Reconstructive Mastectomy
Florence
 HDR database
  Conservative 72.8% (123) 0 0 72.8% (123)
  Reconstructive 0 16% (27) 0 16% (27)
 Mastectomy 0.6%a (1) 2.4%b (4) 8.3% (14) 11.2% (19)
 Total 73.4% (124) 18.3% (31) 8.3% (14) 100% (169)
Pisa
 HDR database
  Conservative 52.1% (87) 0 0 52.1% (87)
  Reconstructive 0 38.3% (64) 0 38.3% (64)
  Mastectomy 0 0 9.6% (16) 9.6% (16)
 Total 52.1% (87) 38.3% (64) 9.6% (16) 100% (167)
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results are based on HDRs, a population-based data-
base, that has been increasingly used to assess quality of 
care at national level and proved to have a good reliabil-
ity for breast cancer cases [32]. The development and 
update of measures to monitor and assess the quality 
of healthcare pathways, such as cancer care, are crucial 
steps for the quality improvement and have to be shared 
with health professionals. Indeed, the improvement 
strategies are more effective when the professionals 
involved in the care pathway take part in the systematic 
data analysis by means a peer-review process. This 
approach makes health professionals more aware of the 
quality of services they contribute to produce and more 
likely to adopt or implement quality improvement strat-
egies [28].
Concerning limitations, the use of HDRs has also short-
comings. Because of the administrative nature of this 
database, there could be some variability in ICD-9-CM 
coding practices between hospitals and professionals 
and miscoding can be possible. Moreover, administrative 
database does not include clinical information on tumor 
size or staging. Therefore, comparison between our indi-
cators and EUSOMA indicators might be hindered by the 
difference in the denominator definition. In fact, when 
we calculated our indicators using the same criteria as 
EUSOMA to exclude tumors >3 cm, we found some dis-
crepancies with those calculated using only HDR data, 
but differences were not significant. Lastly, an easier 
access to plastic surgery for patients admitted to teach-
ing hospital could be a bias for breast surgery indicators 
when comparing teaching and non-teaching hospital. 
However working on the systematic review of coding 
procedures and disseminating the updated algorithms 
among professionals can reduce mistakes in HDR coding 
and, in turn, partial out some of the unwarranted vari-
ability in results.
Future studies are needed to examine in deeper detail 
the impact that clinical, organizational and preference 
related reasons have on the surgeon’s and women’s choice 
of the surgical procedure and to observe whether the 
monitoring of the three procedures over time will allow 
reducing the variability in the surgical practice across 
hospitals.
Conclusions
The engagement of professionals in the revision pro-
cess of the BCS indicator allowed to detect effectively 
the “bug” of the BCS indicator and to modify rapidly the 
algorithm used for its calculation. The update of the cri-
teria for monitoring the breast cancer surgical practices 
allowed (I) catching clinical innovation, (II) ensuring that 
measurement and targets were set in a correct way, and 
(III) addressing the improvement process. Considering 
how strong the effect of control measures in guiding pro-
fessionals’ behavior can be, it is important to avoid mis-
leading indicators where maybe the targets are achieved 
but the real point is missed [33]. This is possible if pro-
fessionals themselves consider these indicators as a work 
tool. Lastly, only the synergic work among professionals, 
managers and researchers can ensure the use of a com-
mon language that is the first step of a common path 
towards the improvement of quality of the health care 
services.
Fig. 1 Percentage of interventions by age group in the teaching 
hospital of Florence (top) and Pisa (bottom)
Page 7 of 8Murante et al. BMC Res Notes  (2017) 10:288 
Abbreviations
BCS: breast-conserving surgery; HDR: hospital discharge record; SR: surgical 
registry; NHS: National health care system; TH: teaching hospital.
Authors’ contributions
AMM, SC and PR co-wrote the manuscript with contributions from all other 
authors; MPF and SN conceived of the study and contributed to study design 
and coordination of the study; MR, MG and AM contributed to acquisition 
of the data and their interpretation; PR performed the statistical analysis and 
contributed to data interpretation. All authors read and approved the final 
manuscript.
Author details
1 Scuola Superiore Sant’Anna, Istituto di Management, Laboratorio Manage-
ment e Sanità, Piazza Martiri della Libertà 33, 56127 Pisa, Italy. 2 Department 
of Biomedical and Neuromotor Sciences, Alma Mater Studiorum-University 
of Bologna, Via San Giacomo 12, 40126 Bologna, Italy. 3 Breast Cancer Surgical 
Unit, University Hospital Trust of Pisa, Via Roma 67, 56126 Pisa, Italy. 4 Hos-
pital Administration, University Hospital Trust “Careggi”, Largo Brambilla 3, 
50134 Florence, Italy. 
Competing interests
The authors declare that they have no competing interests.
Availability of data and materials
The datasets used and analysed during the current study are available from 
the corresponding author on reasonable request.
Ethics approval and consent to participate
The study was exempt from approval from the Ethics Committee of the 
Hospital Trusts of Firenze and Pisa. It was conducted in conformity with the 
regulations for data management from the Regional Health Authority of Tus-
cany, and with the Italian Code of conduct and professional practice applying 
to processing of personal data for statistical and scientific purposes (art. 20–21, 
legislative decree 196/2003; http://www.garanteprivacy.it/web/guest/home/
docweb/-/docweb-display/docweb/1115480) published in the Official Jour-
nal no. 190 of August 14, 2004, which explicitly exempts the need for approval 
from the Ethics Committee when using anonymous data (Preamble Number 
8) [34]. In Italy, anonymous administrative data-gathering is subject to the law 
Protection of individuals and other subjects with regard to the processing 
of personal data, ACT no. 675 of 31.12.1996 (amended by Legislative Decree 
no. 123 of 09.05.1997, no. 255 of 28.07.1997, no. 135 of 08.05.1998, no. 171 of 
13.05.1998, no. 389 of 6.11.1998, no. 51 of 26.02.1999, no. 135 of 11.05.1999, 
no. 281 of 30.07.1999, no. 282 of 30.07.1999 and no. 467 of 28.12.2001) (http://
www.privacy.it/legge675encoord.html). Data were anonymised prior to the 
analysis and each patient was assigned a unique identifier that eliminates the 
ability to trace the patient’s identity or other sensitive data. As anonymised 
administrative data are used routinely for healthcare management and quality 
improvement, no specific written informed consent was needed to use the 
patient information. All procedures performed in this study were in accord-
ance with the 1964 Helsinki Declaration and its later amendments.
Funding
This work is based on the results of a project funded with a grant of Tuscany 
Region in 2014.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in pub-
lished maps and institutional affiliations.
Received: 24 September 2015   Accepted: 7 July 2017
References
 1. Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, Rosso S, Coebergh 
JWW, Comber H, Forman D, Bray F. Cancer incidence and mortality 
patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer. 
2013;49:1374–403.
 2. Stordeur S, Vrijens F, Devriese S, Beirens K, Van Eycken E, Vlayen J. Devel-
oping and measuring a set of process and outcome indicators for breast 
cancer. Breast. 2012;21:253–60.
 3. Ferrua M, Couralet M, Nitenberg G, Morin S, Serin D, Minvielle E. Develop-
ment and feasibility of a set of quality indicators relative to the timeliness 
and organisation of care for new breast cancer patients undergoing 
surgery. BMC Health Serv Res. 2012;12:167.
 4. McCarthy M, Gonzalez-Izquierdo A, Sherlaw-Johnson C, Khachatryan A, 
Coleman MP, Rachet B. Comparative indicators for cancer network man-
agement in England: availability, characteristics and presentation. BMC 
Health Serv Res. 2008;8:45.
 5. Del Turco MR, Ponti A, Bick U, Biganzoli L, Cserni G, Cutuli B, Decker T, 
Dietel M, Gentilini O, Kuehn T, Mano MP, Mantellini P, Marotti L, Poortmans 
P, Rank F, Roe H, Scaffidi E, van der Hage JA, Viale G, Wells C, Welnicka-
Jaskiewicz M, Wengstöm Y, Cataliotti L. Quality indicators in breast cancer 
care. Eur J Cancer. 2010;46:2344–56.
 6. Wilson ARM, Marotti L, Bianchi S, Biganzoli L, Claassen S, Decker T, Frigerio 
A, Goldhirsch A, Gustafsson EG, Mansel RE, Orecchia R, Ponti A, Poort-
mans P, Regitnig P, Rosselli Del Turco M, Rutgers EJT, van Asperen C, Wells 
CA, Wengström Y, Cataliotti L. The requirements of a specialist Breast 
Centre. Eur J Cancer. 2013;49:3579–87.
 7. Blamey RW, Cataliotti L. EUSOMA accreditation of breast units. Eur J 
Cancer. 2006;42:1331–7.
 8. Van Hoeve J, de Munck L, Otter R, de Vries J, Siesling S. Quality improve-
ment by implementing an integrated oncological care pathway for 
breast cancer patients. Breast. 2014;23:364–70.
 9. Sacerdote C, Bordon R, Pitarella S, Mano MP, Baldi I, Casella D, Di 
Cuonzo D, Frigerio A, Milanesio L, Merletti F, Pagano E, Ricceri F, Rosso 
S, Segnan N, Tomatis M, Ciccone G, Vineis P, Ponti A. Compliance with 
clinical practice guidelines for breast cancer treatment: a population-
based study of quality-of-care indicators in Italy. BMC Health Serv Res. 
2013;13:28.
 10. Jeevan R, Cromwell DA, Browne JP, Caddy CM, Pereira J, Sheppard C, 
Greenaway K, van der Meulen JHP. Findings of a national comparative 
audit of mastectomy and breast reconstruction surgery in England. J Plast 
Reconstr Aesthet Surg. 2014;67:1333–44.
 11. Escribà JM, Pareja L, Esteban L, Gálvez J, Melià A, Roca L, Clèries R, Sanz X, 
Bustins M, Pla MJ, Gil MJ, Borrás JM, Ribes J. Trends in the surgical proce-
dures of women with incident breast cancer in Catalonia, Spain, over a 
7-year period (2005–2011). BMC Res Notes. 2014;7:587.
 12. Langagergaard V, Garne JP, Vejborg I, Schwartz W, Bak M, Lernevall A, 
Mogensen NB, Larsson H, Andersen B, Mikkelsen EM. Existing data 
sources for clinical epidemiology: the Danish quality database of mam-
mography screening. Clin Epidemiol. 2013;5:81–8.
 13. Nuti S, Bonini A. Il Sistema Di Valutazione Della Performance Dei Sistemi 
Sanitari Regionali : Basilicata, Emilia-Romagna, Friuli Venezia Giulia, Ligu-
ria, Marche, P.A. Bolzano, P.A. Trento, Toscana, Umbria, Veneto—REPORT 
2013. Pisa: ETS; 2013.
 14. Nuti S, Fantini MP, Murante AM. Valutare I Percorsi in Sanità. I Percorsi 
Della Salute Mentale E Il Percorso Oncologico. Il Mulino; 2014.
 15. Tuscany Regional Committee Resolution March 31 2014, n. 272, “Riordino 
della Rete chirurgica oncologica toscana: primi indirizzi alle Aziende 
Sanitarie per la costituzione della Rete dei Centri di Senologia e requisiti 
organizzativo-assistenziali degli stessi”.
 16. Powell AE, Davies HTO, Thomson RG. Using routine comparative data to 
assess the quality of health care: understanding and avoiding common 
pitfalls. Qual Saf Health Care. 2003;12:122–8.
 17. Flamholtz EG, Das TK, Tsui AS. Toward an integrative framework of organi-
zational control. Account Organ Soc. 1985;10:35–50.
 18. Otley D. Performance management: a framework for management 
control systems research. Manag Account Res. 1999;10:363–82.
 19. Krotneva SP, Reidel KE, Verma A, Mayo N, Tamblyn R, Meguerditchian AN. 
Factors influencing the quality of local management of ductal carcinoma 
in situ: a cohort study. Curr Oncol. 2013;20:e212–22.
 20. Peltoniemi P, Peltola M, Hakulinen T, Häkkinen U, Pylkkänen L, Holli K. The 
effect of hospital volume on the outcome of breast cancer surgery. Ann 
Surg Oncol. 2011;18:1684–90.
 21. McDermott AM, Wall DM, Waters PS, Cheung S, Sibbering M, Horgan 
K, Kearins O, Lawrence G, Patnick J, Kerin MJ. Surgeon and breast unit 
volume-outcome relationships in breast cancer surgery and treatment. 
Ann Surg. 2013;258:808–13 (discussion 813–4).
Page 8 of 8Murante et al. BMC Res Notes  (2017) 10:288 
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
 22. Vrijens F, Stordeur S, Beirens K, Devriese S, Van Eycken E, Vlayen J. Effect of 
hospital volume on processes of care and 5-year survival after breast can-
cer: a population-based study on 25000 women. Breast. 2012;21:261–6.
 23. Nuti S, Seghieri C, Vainieri M. Assessing the effectiveness of a per-
formance evaluation system in the public health care sector: some 
novel evidence from the Tuscany region experience. J Manag Gov. 
2012;17:59–69.
 24. Reinertsen JL, Rupp W, Whittington J. Engaging physicians in a shared 
quality Agenda. Cambridge: Institute for Healthcare Improvement Inno-
vation Series White Paper; 2007. p. 2007.
 25. Spurgeon P, Mazelan PM, Barwell F. Medical engagement: a crucial 
underpinning to organizational performance. Health Serv Manage Res. 
2011;24:114–20.
 26. Clark J. Medical leadership and engagement: no longer an optional extra. 
J Health Organ Manag. 2012;26:437–43.
 27. Gray M, El Turabi A. Optimising the value of interventions for populations. 
BMJ. 2012;345:e6192.
 28. Wilkinson J, Powell A. Are clinicians engaged in quality improvement ?. 
London: The Health Foundation; 2011.
 29. Coopey SB, Tang R, Lei L, Freer PE, Kansal K, Colwell AS, Gadd MA, Specht 
MC, Austen WG, Smith BL. Increasing eligibility for nipple-sparing mastec-
tomy. Ann Surg Oncol. 2013;20:3218–22.
 30. Garcia-Etienne CA, Forcellini D, Sagona A, Caviggioli F, Barbieri E, Corneg-
liani G, Giannasi S, Tinterri C. Breast reconstruction: a quality measure for 
breast cancer care? Breast. 2012;21:105–6.
 31. Yang RL, Newman AS, Lin IC, Reinke CE, Karakousis GC, Czerniecki BJ, Wu LC, 
Kelz RR. Trends in immediate breast reconstruction across insurance groups 
after enactment of breast cancer legislation. Cancer. 2013;119:2462–8.
 32. Yuen E, Louis D, Cisbani L, Rabinowitz C, De Palma R, Maio V, Leoni M, 
Grilli R. Using administrative data to identify and stage breast cancer 
cases: implications for assessing quality of care. Tumori. 2011;97:428–35.
 33. Bevan G, Hood C. What’s measured is what matters: targets and gaming 
in the English public health care system. Public Adm. 2006;84:517–38.
 34. D. lgs. July 30 2003, n. 196, “Codice in materia di protezione dei dati 
personali”.
